Published On Feb 28, 2023
This biotech stock is set to see huge sales growth, and it's conservatively valued with $2 billion in cash!
This makes it a hot target for a big pharma company to buy them.
Want to take a deeper dive?
https://paulmampilly.substack.com/
Looking for guidance on our stocks?π
https://www.atgdigital.media/
show more